Last reviewed · How we verify
NCT03548870: proTENS
Transcutaneous Electrical Nerve Stimulation During Exercise in Patients With COPD
NA trial testing CWRT with low frequency transcutaneous electrical nerve stimulation in COPD in 2 participants. Terminated before completion.
8 October 2023
Quick facts
| Lead sponsor | Groupe Hospitalier du Havre |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 23 October 2021 |
| Primary completion | 8 October 2023 |
| Estimated completion | 8 October 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- CWRT with low frequency transcutaneous electrical nerve stimulation
- CWRT with sham-low frequency transcutaneous electrical nerve stimulation
Conditions studied
- COPD — all drugs for COPD →
- Physical Activity — all drugs for Physical Activity →
- Rehabilitation — all drugs for Rehabilitation →
- TEN — all drugs for TEN →
Sponsor
Groupe Hospitalier du Havre
Who can join
Adults 35 to 80, any sex, with COPD or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. Several studies showed that transcutaneous electrical nerve stimulation (TENS) could improve dyspnea and pulmonary function. The aim of this study is to assess the acute effect of TENS on exercise tolerance in post-exacerbation COPD patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03548870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COPD
Currently open trials in the same condition.
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
- NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
Other Groupe Hospitalier du Havre trials
Trials by the same sponsor.
- NCT07371754 — Shear Wave Elastography of Intercostal Muscles for the Non-invasive Assessment of the Work of BreathinG · not yet recruiting
- NCT07492745 — Effect of Using a Reminder to Encourage Patients to be Active During Their Hospital Stay. · NA · recruiting
- NCT06994689 — Clinimetric Properties of Muscle Mass and Stiffness Measurements of the Quadriceps in Patients With COPD · recruiting
- NCT06249412 — The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients · NA · recruiting
- NCT06772701 — Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03548870 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Groupe Hospitalier du Havre
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03548870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing